Stocks and Sips - Xenitra Ltd (ASX:XEN)

Anthony was appointed Non-Executive Chairman in March 2025. He has more than 20 years’ experience working across life sciences, consumer health, and international trade, with a focus on building partnerships and creating sustainable growth. Anthony holds a PhD in Stem Cell Biology and an Executive MBA from the Australian Graduate School of Management, including a year at the Wharton School (UPenn). His career has spanned from biotechnology research and clinical development to operational and commercial leadership roles in both listed and private companies. He currently serves as Executive Director at Servatus Biopharmaceuticals and Biomiq Skincare. He previously was CEO of The Calmer Co. Ltd and Australian Biotherapeutics. Anthony spent a decade in various roles within the SFI Health Group where he was Global Head of Innovation and spearheaded market expansion initiatives via both organic growth and multiple M&A transactions in Europe, Australia, North America and in Asia, with a strong focus on the North Asia markets, including serving as General Manager of both SFI-Shineway in China and of SFI-Korea. His focus at Xenitra has been on strengthening the company’s compliance and governance practices, tightening and defining the strategic direction, supporting senior management in China, and ensuring the business is well-positioned to take advantage of growing opportunities in cross-border trade.

Xenitra specialises in fast-moving consumer goods (FMCG), nutraceuticals, over-the-counter (OTC) medicine and personal care products that are sold through a channel optimised sales ecosystem including blockchain tokenised distribution channels spanning Business-to-Business (B2B) trading, retail distribution and all major ecommerce platforms in China. Xenitra works with leading international brands as a market entry and sales acceleration partner for Asian markets. Through our proprietary platform, we have a proven track record of delivering exceptional market integration, providing marketing insights and delivering sales velocity for brands in China.